Cartesian Therapeutics

About:

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

Website: https://www.cartesiantherapeutics.com/

Top Investors: Invus, National Heart, Lung and Blood Institute, Surveyor Capital, Schooner Capital, HBM Healthcare Investments

Description:

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.

Total Funding Amount:

$132M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Gaithersburg, Maryland, United States

Founded Date:

2016-01-01

Founders:

Michael S. Singer, Murat V. Kalayoglu

Number of Employees:

11-50

Last Funding Date:

2024-07-02

IPO Status:

Public

Industries: